Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
about
Structure of the wild-type human BCL6 POZ domainStructure of the human Nac1 POZ domainB cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus.POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and functionCell of origin determines clinically relevant subtypes of MLL-rearranged AMLUsing biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma.Genomic tools for dissecting oncogenic transcriptional networks in human leukemia.miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictionsGenetic and molecular targets in lymphoma: implications for prognosis and treatment.A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma.
P2860
Q27653027-4994C810-FBDF-42CC-B647-1820C96FED88Q27655343-3D76EBA2-6539-4432-8545-391528B4BA28Q34950531-B68BF062-8C54-4EF0-A432-D8C53BBB1C49Q35906761-59082B5E-B062-427B-9A50-5B0F8C7ED056Q36409664-409309A8-8FBF-4D5A-9BD0-AD6381315722Q36776444-8F9B9483-D2D1-47A5-BAAF-BF0F419B127EQ37184358-4E76ACC7-B932-4B1A-B30F-0E218C49BAA6Q37374239-765F18FD-2728-455A-A86B-504482DA9270Q37548900-7896E43B-2425-4591-8D86-34B3DE1A231FQ37618835-42718A51-94CE-4805-AE37-9F3DE9F39AC0Q38022591-E05227CE-AEC4-41F2-87C2-098C00160512Q38294626-E1240F8E-4F33-4000-AC19-7FE5A5D3C173Q39116273-B97A8233-E29D-4F9E-9633-B5F144951EB7Q39358270-7D6E2F81-AB77-4C46-81F4-58A76D776C24Q39718902-99CCB38B-4DCA-44C4-94E7-FC58132DC3A7
P2860
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@en
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@nl
type
label
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@en
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@nl
prefLabel
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@en
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@nl
P2093
P2860
P1433
P1476
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.
@en
P2093
Ari Melnick
Gilbert Privé
Samir Parekh
P2860
P304
P356
10.1080/10428190801895345
P577
2008-05-01T00:00:00Z